Phase | Originator | Common name | Specificity target | Target disease |
2 | Immunomedics | IMMU-130 | anti-CEACAM5 | CRC |
2 | Immunomedics | IMMU-132 | anti-TROP-2 | solid tumors |
Phase | Originator | Common name | Specificity target | Target disease |
2 | Immunomedics | IMMU-130 | anti-CEACAM5 | CRC |
2 | Immunomedics | IMMU-132 | anti-TROP-2 | solid tumors |